Larvol Delta - Concomitant-use-of-glucagonlike-peptide1-receptor-agonists-in-patients-with-psoriasis-or-hidradenitis-suppurativa-receiving-bimekizumab-Crosssectional-analysis-of-US-claims-data

Bimzelx (bimekizumab-bkzx) - UCB

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/63019

Martina L. Porter

Aug 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next